Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Analgesia following Autologous Breast Reconstruction
NCT03007381Phase 4Withdrawn
- Sponsor
- Nova Scotia Health
- Start
- Nov 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ketorolac in pain, sponsored by Nova Scotia Health. Planned start Nov 2017; status: withdrawn.
02
Drugs
ketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT03007381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007381.